[ET Net News Agency, 2 July 2025] Citi raised the target price for Innovent Bio (01801)
to HKD90 from HKD60 and upgraded the rating to "buy" from "buy/high risk".
The research house said Innovent Bio has entered into a new stage, driven by strong
commercial performance and global innovation. (rc)
|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01801 INNOVENT BIO
Nominal 
82.000 +1.450 (+1.800%) Others
02/07/2025 15:30
{I-bank focus}Citi raises Innovent Bio (01801) to HKD90
Next︰26/06/2025 09:49 {Block Trade}INNOVENT BIO (01801): 302k shares, or HK$23.66m
26/06/2025 09:35 {Block Trade}INNOVENT BIO (01801): 480k shares, or HK$37.9m
23/06/2025 14:25 {Block Trade}INNOVENT BIO (01801): 290k shares, or HK$22.83m
10/06/2025 14:42 {I-bank focus}J.P. Morgan raises Innovent Bio to HKD84
10/06/2025 09:01 {Block Trade}Trading session block trades at 9:00am
05/06/2025 14:59 {I-bank focus}BOCI raises Innovent Bio (01801) to HKD82
| Remark: | Real time quote last updated: 14/07/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service |